1. Volume 71, Issue 2, Pages 151-154 (February 2017)
Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study 
Tomasz M. Beer, Andrew J. Armstrong, Dana Rathkopf, Yohann Loriot, Cora N. Sternberg, Celestia S. Higano, Peter Iversen, Christopher P. Evans, Choung-Soo Kim, Go Kimura, Kurt Miller, Fred Saad, Anders S. Bjartell, Michael Borre, Peter Mulders, Teuvo L. Tammela, Teresa Parli, Suha Sari, Steve van Os, Ad Theeuwes, Bertrand Tombal 
European Urology 
Volume 71, Issue 2, Pages (February 2017)
DOI: /j.eururo
Copyright © 2016 European Association of Urology Terms and Conditions

2. Fig. 1
Kaplan-Meier estimates of radiographic progression-free survival (rPFS) and overall survival (OS) at the extended analysis. Dashed horizontal lines indicate median values. CI=confidence interval; HR=hazard ratio; NYR=not yet reached.
European Urology  , DOI: ( /j.eururo )
Copyright © 2016 European Association of Urology Terms and Conditions